Selvita S.A. Acquires PozLab
May 7, 2024
Selvita S.A. has completed the acquisition of 100% of the shares in PozLab, a Poznan-based CDMO providing drug product development, analytical and microbiological testing, and small pilot plant manufacturing under GMP. The deal expands Selvita's service offering beyond preclinical research into small-molecule drug manufacturing for early-stage clinical trials and strengthens its position in the pharmaceutical research value chain.
- Buyers
- Selvita S.A.
- Targets
- PozLab
- Industry
- Pharmaceuticals
- Location
- Greater Poland Voivodeship, Poland
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Kuva Labs Acquires Lisata Therapeutics
March 6, 2026
Pharmaceuticals
Kuva Labs, Inc. has entered into a definitive agreement to acquire Lisata Therapeutics, Inc. for $5.00 per share in cash, plus a contingent value right (CVR) that could pay an additional $1.00 per share upon an FDA-related regulatory milestone tied to certepetide. The transaction is expected to close in the second quarter of 2026, subject to customary tender offer conditions, including tender of a majority of Lisata’s outstanding shares.
-
Beckman Coulter Life Sciences Acquires ValitaCell Ltd.
September 13, 2022
Biotechnology
Beckman Coulter Life Sciences, a Danaher company, has acquired Dublin-based ValitaCell Ltd., a developer of analytical products and technologies for the biopharmaceutical industry. The acquisition adds ValitaCell’s ValitaTiter and related cell-analytics products to Beckman Coulter’s portfolio to accelerate biologics development and manufacturing workflows.
-
Cemvita Factory Acquires Solfatara Laboratories
June 14, 2022
Industrial Services
Cemvita Factory acquired Denver-based Solfatara Laboratories to accelerate development and scale-up of its biomining capabilities, including Solfatara’s scale-up facility in Golden, Colorado. Solfatara’s founder Tom Clark joins Cemvita as Head of Biohydrometallurgy to support bioleaching, bio-oxidation and acid mine drainage monitoring work as Cemvita prepares for commercial field deployment of biomining technologies.
-
Solvias Acquires Chemic Laboratories to Establish U.S. Laboratory Presence
June 17, 2021
Healthcare Services
Solvias has acquired Canton, Massachusetts-based Chemic Laboratories, Inc., giving the Swiss analytical testing and contract research company a U.S. foothold and complementary laboratory testing capabilities. Chemic's co-founders will join Solvias' leadership and continue to run U.S. operations; financial terms were not disclosed.
-
Curative Inc. Acquires KorvaLabs, Inc.
May 19, 2020
Healthcare Services
Curative Inc. has acquired KorvaLabs, a CLIA-certified and DEA-licensed analytical laboratory based in San Dimas, California, formalizing a partnership that supported Curative's manufacture and processing of its oral fluid COVID-19 test. The acquisition strengthens Curative's testing capacity — to date the organizations processed 245,371 tests together and were processing roughly 14,000 tests per day — and secures in-house manufacturing and processing capabilities.
-
Lonza AG Acquires PharmaCell BV
June 1, 2017
Biotechnology
Lonza AG has completed the acquisition of PharmaCell BV, a leading European contract manufacturer of cell and gene therapies with facilities in Maastricht and Sittard-Geleen. The deal expands Lonza's autologous cell-therapy manufacturing capabilities in Europe and integrates PharmaCell's GMP production capacity and experienced team into Lonza's global CDMO network.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.